OSHKOSH CORP (OSK)

US6882392011 - Common Stock

73.93  -0.16 (-0.22%)

After market: 73.93 0 (0%)


Fundamental Rating

5

Overall OSK gets a fundamental rating of 5 out of 10. We evaluated OSK against 154 industry peers in the Machinery industry. The financial health of OSK is medium. Also its profitability is quite bad. OSK is not valued too expensively and it also shows a decent growth rate.




Profitability

Profitability Rating

2

OSK has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for OSK.
OSK's Return On Assets of 3.34% is worse than the rest of the industry. The industry average Return On Assets is 5.26%.

OSK's Return On Equity of 8.15% is worse than the rest of the industry. The industry average Return On Equity is 14.20%.
OSK has a Profit Margin of 3.07%. This is below the industry average of 7.76%. 85% of the industry peers outperform OSK.
VS Industry

ROA (3.34%) VS Industry: 24% outperformed.

0.01
27.15

ROE (8.15%) VS Industry: 34% outperformed.

0.02
99.55

Profit Margin (3.07%) VS Industry: 15% outperformed.

0.01
41.07

Valuation

Valuation Rating

6

With a Forward Price/Earnings Ratio of 10.26, the valuation of OSK can be described as very reasonable.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the Enterprise Value to EBITDA ratio of OSK to the average industry ratio of 12.11, OSK is valued rather cheaply.
With a Price/Earnings Ratio of 16.07, OSK is valued correctly.

Compared to an average industry Price/Earning Ratio of 18.83, OSK is valued in line with its industry peers.
With a price book ratio of 1.49, OSK is valued correctly.
When comparing the price book ratio of OSK to the average industry price book ratio of 2.21, OSK is valued in line with its industry peers.
VS Industry

Price/Earnings (16.07) VS Industry: 60% outperformed.

137.94
4.59

Price/Book (1.49) VS Industry: 59% outperformed.

964.44
0.05

Enterprise Value/ EBITDA (8.24) VS Industry: 76% outperformed.

122.16
1.11

Growth

Growth Rating

6

The Earnings Per Share has grown by an impressive 60.84% over the past year.
Based on estimates for the next 5 years, OSK will show a very strong growth in Earnings Per Share. The EPS will grow by 23.59% on average per year.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
OSK shows a decrease in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -5.18% yearly.

OSK shows a small growth in Revenue. In the last year, the Revenue has grown by 7.43%.
Measured over the past 5 years, OSK shows a small growth in Revenue. The Revenue has been growing by 3.93% on average per year.
The Revenue is expected to grow by 3.02% on average over the next 5 years.
The Revenue growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-5.18% -26.9% 60.84% 74.65% 48.93% 38.45% 23.59%
Revenue3.93% -0.4% 7.43% 2.3% 3.12% 3.31% 3.02%

Health

Health Rating

5

With a Debt to Equity ratio of 0.18, OSK is doing better than the averages in the industry. The industry average is at 0.39.
The Piotroski-F score of OSK is 7.00. This is a strong score and indicates good health and profitability for OSK.
A Current Ratio of 1.80 indicates that OSK should not have too much problems paying its short term obligations.
OSK has a Quick Ratio of 1.02. This is a normal value and indicates that OSK is financially healthy and should not expect problems in meeting its short term obligations.

OSK has a Quick Ratio comparable to the industry average, which is at 1.20.
OSK has an Altman-Z score of 2.80. This is not the best score and indicates that OSK is in the grey zone with still only limited risk for bankruptcy at the moment.
OSK has a Altman-Z score comparable to the industry average, which is at 2.76.
Compared to an average industry Current Ratio of 2.00, OSK is worse placed to pay its short term obligations than its industry peers.
VS Industry

Debt/Equity (0.18) VS Industry: 67% outperformed.

5.74
0.00

Quick Ratio (1.02) VS Industry: 42% outperformed.

0.06
21.22

Current Ratio (1.8) VS Industry: 39% outperformed.

0.10
21.28

Altman-Z (2.8) VS Industry: 51% outperformed.

-15.58
33.84

Dividend

Dividend Rating

7

Compared to an average industry Dividend Yield of 1.41, OSK pays a bit more dividend than its industry peers.
The dividend of OSK is nicely growing with an annual growth rate of 11.77%!
OSK's earnings are growing more than its dividend. This makes the dividend growth sustainable.
37.66% of the earnings are spent on dividend by OSK. This is a low number and sustainable payout ratio.

OSK has paid a dividend for at least 10 years, which is a reliable track record.
OSK has a Yearly Dividend Yield of 2.21%. Purely for dividend investing, there may be better candidates out there.
Compared to an average S&P500 Dividend Yield of 2.72, OSK has a dividend comparable with the average S&P500 company.
VS Industry

Dividend Yield (2.21%) VS Industry: 73% outperformed.

0.14
19.70

OSHKOSH CORP

NYSE:OSK (5/26/2023, 7:04:00 PM)

After market: 73.93 0 (0%)

73.93

-0.16 (-0.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-27 2023-04-27/bmo
Earnings (Next)07-26 2023-07-26/bmo
Inst Owners90.12%
Inst Owner Change-1.13%
Ins Owners0.68%
Ins Owner Change9.27%
Market Cap4.83B
Analysts69.57
Price Target93.42 (26.36%)
Dividend
Industry RankSector Rank
Dividend Yield 2.21%
Dividend Growth(5Y)11.77%
DP37.66%
Div Incr Years9
Div Non Decr Years9
Ex-Date05-12 2023-05-12 (0.41)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)23.05%
Min EPS beat(2)-8.54%
Max EPS beat(2)54.63%
EPS beat(4)1
Avg EPS beat(4)-6.85%
Min EPS beat(4)-54.19%
Max EPS beat(4)54.63%
Revenue beat(2)1
Avg Revenue beat(2)3.84%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)7.75%
Revenue beat(4)1
Avg Revenue beat(4)-1.36%
Min Revenue beat(4)-7.73%
Max Revenue beat(4)7.75%
PT rev (1m)-5.58%
PT rev (3m)-10.57%
EPS NQ rev (1m)8.04%
EPS NQ rev (3m)-6.64%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.11%
Revenue NQ rev (1m)4.33%
Revenue NQ rev (3m)1.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.23%
Valuation
Industry RankSector Rank
PE 16.07
Fwd PE 10.26
P/S 0.56
P/FCF N/A
P/OCF 13.71
P/B 1.49
P/tB 3.05
EV/EBITDA 8.24
EPS(TTM)4.6
EY6.22%
EPS(NY)7.21
Fwd EY9.75%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)5.39
OCFY7.29%
SpS131.74
BVpS49.72
TBVpS24.22
PEG (NY)0.22
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.34%
ROE 8.15%
ROIC 7.04%
ROICexc 7.81%
ROICexgc 11.81%
OM 5.6%
PM 3.07%
GM 13.79%
ROICexgc(3y)17.29%
ROICexcg growth 3Y-32.32%
ROICexcg growth 5Y-17.14%
ROICexc(3y)10.24%
ROICexc growth 3Y-28.99%
ROICexc growth 5Y-11.8%
OM growth 3Y-21.56%
OM growth 5Y-7.8%
PM growth 3Y-32.78%
PM growth 5Y-12.87%
GM growth 3Y-11.07%
GM growth 5Y-5.94%
F-Score7
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 1.01
Cap/Depr 326.23%
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.02
Altman-Z 2.8
F-Score7
WACC8.76%
ROIC/WACC1.35
Cap/Depr(3y)165.09%
Cap/Depr(5y)145.91%
Profit Quality(3y)159.94%
Profit Quality(5y)123.82%
Growth
EPS 1Y60.84%
EPS 3Y-26.9%
EPS 5Y-5.18%
EPS growth Q2Q562.5%
EPS Next Y74.65%
EPS Next 2Y48.93%
EPS Next 3Y38.45%
EPS Next 5Y23.59%
Revenue growth 1Y7.43%
Revenue growth 3Y-0.4%
Revenue growth 5Y3.93%
Revenue growth Q2Q16.57%
Revenue Next Year2.3%
Revenue Next 2Y3.12%
Revenue Next 3Y3.31%
Revenue Next 5Y3.02%
EBIT growth 1Y35.56%
EBIT growth 3Y-21.88%
EBIT growth 5Y-4.17%
EBIT Next Year86.42%
EBIT Next 3Y34.4%
EBIT Next 5Y17.53%
FCF growth 1Y-101.22%
FCF growth 3Y-6.55%
FCF growth 5Y19.26%
OCF growth 1Y-64.72%
OCF growth 3Y1.9%
OCF growth 5Y19.52%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA